Angiotech Pharmaceuticals, Inc.
| OTC Markets: ANPMF
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, primarily within the areas of interventional oncology, wound closure and ophthalmology. The company operates its business through two segments: Medical Device Technologies and Licensed Technologies. The Medical Device Technologies segment develops, manufactures and markets a wide range of single use medical device products, as well as precision manufactured medical device components. Its products and components are sold directly to hospitals, clinics, physicians and other end users, as well as to medical products distributors or other third-party medical device manufacturers. The Licensed Technologies segment includes legacy technologies for research and development activities. Angiotech Pharmaceuticals was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada.